A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Ginkgo biloba
Metahexamide
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Metahexamide.
Ginkgo biloba
Guar gum
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Guar gum.
Ginkgo biloba
Carbutamide
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Carbutamide.
Ginkgo biloba
Remogliflozin etabonate
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Remogliflozin etabonate.
Ginkgo biloba
Balaglitazone
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Balaglitazone.
Ginkgo biloba
Sotagliflozin
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Sotagliflozin.
Ginkgo biloba
Evogliptin
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Evogliptin.
Ginkgo biloba
Anagliptin
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Anagliptin.
Ginkgo biloba
Gemigliptin
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Gemigliptin.
Ginkgo biloba
Carmegliptin
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Carmegliptin.
Ginkgo biloba
Omarigliptin
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Omarigliptin.
Ginkgo biloba
Teneligliptin
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Teneligliptin.
Ginkgo biloba
2,4-thiazolidinedione
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with 2,4-thiazolidinedione.
Ginkgo biloba
Tofogliflozin
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Tofogliflozin.
Ginkgo biloba
Allicin
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Allicin.
Ginkgo biloba
Dutogliptin
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Dutogliptin.
Ginkgo biloba
Ipragliflozin
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Ipragliflozin.
Ginkgo biloba
Insulin tregopil
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Insulin tregopil.
Ginkgo biloba
Insulin peglispro
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Insulin peglispro.
Ginkgo biloba
Insulin degludec
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Insulin degludec.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3